C1orf63 silencing affects breast cancer cell proliferation, apoptosis, and cycle distribution by NF-κB signaling pathway

被引:3
作者
Zhang, Lijun [1 ]
Zhang, Hua [2 ]
Li, Yaqiong [3 ]
Wang, Lingcheng [3 ]
机构
[1] First Peoples Hosp Jingzhou, Dept Breast Surg, Jingzhou, Hubei, Peoples R China
[2] Hubei Univ Med, Affiliated Taihe Hosp, Dept Gen Surg Ward 3, Shiyan, Hubei, Peoples R China
[3] Hubei Univ Med, Renmin Hosp, Dept Thyroid Breast & Vasc Surg, 39 Chaoyang Middle Rd, Shiyan 442000, Hubei, Peoples R China
来源
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH | 2021年 / 13卷 / 04期
关键词
C1orf63; breast cancer cell; proliferation; apoptosis; cell cycle; OVARIAN-CANCER; INHIBITION; GROWTH;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To investigate the effect of C1orf63 on breast cancer cell (BCC) proliferation, apoptosis, and cycle distribution and related mechanisms. Methods: The expression of C1orf63 was interfered with in BCC line MCF and cells were divided into a C1orf63 overexpression group, C1orf63 silence group, blank group, and empty group. The mRNA expression of C1orf63 and the proliferation, apoptosis, and cycle distribution of BCCs were detected. The mRNA expression levels of NF-kappa B signaling pathway factors (p-I kappa B alpha, CyclinD1, CDK4, Bcl-2, and Bax) in each group were also detected. Results: There was no significant difference between the blank group and empty group in the expression level of C1orf63 mRNA, cell proliferation rate, apoptosis rate, cell distribution rate, or mRNA expression levels of the NF-kappa B signaling pathway factors (all P>0.05). The expression levels of C1orf63 mRNA in the C1orf63 silenced group were lower than those in the other two groups (P<0.05). The cell proliferation rate, cell distribution in S phase and G2/M phase, and the mRNA expression levels of NF-kappa B signaling pathway factors (p-I kappa B alpha, CyclinD1, CDK4, and Bcl-2) in the C1orf63 silenced group at each time point were lower than those in the other two groups (all P<0.05). The apoptosis rate, cells in G1 phase, and the Bax mRNA expression level in C1orf63 silenced group at each time point were higher than those in the other two groups (all P<0.05). Conclusion: Down regulation of C1orf63 acts on the NF-kappa B signaling pathway to regulate the expression of p-I kappa Ba, CyclinD1, and CDK4, so as to inhibit BCC proliferation, promote cell apoptosis, and block the cell cycle.
引用
收藏
页码:2599 / 2607
页数:9
相关论文
共 23 条
[1]  
Chen DL, 2018, INT J CLIN EXP PATHO, V11, P4735
[2]  
Chinese Anti-Cancer Association and Tianjin Medical University Cancer Institute & Hospital, 2019, CHIN J CLIN ONCOL, V46, P430
[3]  
Ding C, 2019, INT J CLIN EXP PATHO, V12, P2148
[4]   Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity [J].
El-Sisi, Alaa E. ;
Sokkar, Samia S. ;
Ibrahim, Hanaa A. ;
Hamed, Mohamed F. ;
Abu-Risha, Sally E. .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2020, 34 (04) :458-475
[5]   RO3280: A Novel PLK1 Inhibitor, Suppressed the Proliferation of MCF-7 Breast Cancer Cells Through the Induction of Cell Cycle Arrest at G2/M Point [J].
Ergul, Mustafa ;
Bakar-Ates, Filiz .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (15) :1846-1854
[6]  
Fan SJ, 2019, J BUON, V24, P1532
[7]   CineBreast-factors influencing the time to first metastatic recurrence in breast cancer: Analysis of real-life data from the French ESME MBC database [J].
Gougis, P. ;
Carton, M. ;
Tchokothe, C. ;
Campone, M. ;
Dalenc, E. ;
Mailliez, A. ;
Levy, C. ;
Jacot, W. ;
Debled, M. ;
Leheurteur, M. ;
Bachelot, T. ;
Hennequin, A. ;
Perrin, C. ;
Goncalves, A. ;
Uwer, L. ;
Eymard, J. C. ;
Petit, T. ;
Mouret-Reynier, M. A. ;
Chamorey, E. ;
Simon, G. ;
Saghatchian, M. ;
Cailliot, C. ;
Le Tourneau, C. .
BREAST, 2020, 49 :17-24
[8]   Translational Highlights in Breast and Ovarian Cancer 2019-Immunotherapy, DNA Repair, PI3K Inhibition and CDK4/6 Therapy [J].
Hartkopf, Andreas D. ;
Mueller, Volkmar ;
Woeckel, Achim ;
Lux, Michael P. ;
Janni, Wolfgang ;
Ettl, Johannes ;
Belleville, Erik ;
Schuetz, Florian ;
Fasching, Peter A. ;
Kolberg, Hans-Christian ;
Welslau, Manfred ;
Overkamp, Friedrich ;
Taran, Florin-Andrei ;
Brucker, Sara Y. ;
Wallwiener, Markus ;
Tesch, Hans ;
Fehm, Tanja N. ;
Schneeweiss, Andreas ;
Lueftner, Diana .
GEBURTSHILFE UND FRAUENHEILKUNDE, 2019, 79 (12) :1309-1319
[9]   Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced blereast cancers: a retrospective study [J].
Hong, Chao-Qun ;
Zhang, Fan ;
You, Yan-Jie ;
Qiu, Wei-Li ;
Giuliano, Armando E. ;
Cui, Xiao-Jiang ;
Zhang, Guo-Jun ;
Cui, Yu-Kun .
BMC CANCER, 2015, 15
[10]   UBE2C Overexpression Aggravates Patient Outcome by Promoting Estrogen-Dependent/Independent Cell Proliferation in Early Hormone Receptor-Positive and HER2-Negative Breast Cancer [J].
Kim, Yu-Jin ;
Lee, Gyunghwa ;
Han, Jinil ;
Song, Kyoung ;
Choi, Joon-Seok ;
Choi, Yoon-La ;
Shin, Young Kee .
FRONTIERS IN ONCOLOGY, 2020, 9